The dual sword role of metformin, on one hand, known to activate AMPK – which in turn inhibits mTOR and suppresses proliferation—but, on the other hand, has also the potential to increase cancer progression, illustrates the intricacy of this relationship. Here, MTOR is linked to cancer.